Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells. (Q54511046)

30 May 2018

title

Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells. (English)

1 reference

30 May 2018

0 references

0 references

4

1 reference

30 May 2018

author name string

Akio Matsuda

1

1 reference

30 May 2018

Hideaki Morita

2

1 reference

30 May 2018

Hirotoshi Unno

3

1 reference

30 May 2018

Kenji Matsumoto

5

1 reference

30 May 2018

Yutaka Hirao

6

1 reference

30 May 2018

Koji Munechika

7

1 reference

30 May 2018

Jun Abe

8

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 August 2012

1 reference

30 May 2018

European Journal of Immunology

published in

1 reference

30 May 2018

volume

42

1 reference

30 May 2018

issue

8

1 reference

30 May 2018

page(s)

2121-2131

1 reference

30 May 2018

Intravenous immunoglobulin and dendritic cells.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Diagnosis, treatment, and long-term management of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Corticosteroid enhances TNF-alpha-mediated leukocyte adhesion to pulmonary microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

beta2-Adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

IL-33 mediates inflammatory responses in human lung tissue cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Th1/Th2 Cytokines Reciprocally RegulateIn VitroPulmonary Angiogenesis via CXC Chemokine Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

High-dose intravenous gammaglobulin for Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

TNF- Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

Intravenous immunoglobulin G selectively inhibits IL-1α-induced neutrophil-endothelial cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242398

7 January 2021

Identifiers

DOI

10.1002/EJI.201242398

1 reference

30 May 2018

1 reference

30 May 2018